Mechanisms of Thrombus Formation
The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Abstract
Hemostasis is the process that maintains the integrity of a closed, high-pressure circulatory system after vascular damage. Vessel-wall injury and the extravasation of blood from the circulation rapidly initiate events in the vessel wall and in blood that seal the breach. Circulating platelets are recruited to the site of injury, where they become a major component of the developing thrombus; blood coagulation, initiated by tissue factor, culminates in the generation of thrombin and fibrin. These events occur concomitantly (Figure 1A; also see Video, available with the full text of this article at www.nejm.org), and under normal conditions, regulatory mechanisms contain . . .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These endothelial mediators subserve functions as varied as local flow distribution,91 immune surveillance (in concert with perivascular cells),92 and hemostatic balance.93”
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [35]
In the citing paper
“enhanced platelet reactivity and acute thrombotic occlusion of vessels are the proximate cause of myocardial infarction, stroke and the majority of deaths in patients with CVD36.”
From Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential (2018) · cites this paper as [36]
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Platelet Activation and Atherothrombosis
Davì, G., & Patrono, C. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071014 · Cited by 2,135
An Enzyme Cascade in the Blood Clotting Mechanism, and its Function as a Biochemical Amplifier
MACFARLANE, R. G. (1964) · Nature · doi:10.1038/202498a0 · Cited by 1,119
Waterfall Sequence for Intrinsic Blood Clotting
Davie, E. W., & Ratnoff, O. D. (1964) · Science · doi:10.1126/science.145.3638.1310 · Cited by 1,113
The Roles of Protein C and Thrombomodulin in the Regulation of Blood Coagulation
Esmon, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83649-3 · Cited by 1,046
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S., & Gimbrone, M. A. (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.2.618 · Cited by 935
Research works printed but not linked: 4
- Semeraro N, 1983, Immunology, 50, 529
- Reinhardt C, 2008, J Clin Invest, 118, 1110
- Cho J, 2008, J Clin Invest, 118, 1123
- 1986, Lancet, 1, 397
Cited by
Items 201–300 of 1,000
Profiling of the plasma proteome across different stages of human heart failure
Egerstedt, A., Berntsson, J., Smith, M. L., Gidlöf, O., Nilsson, R., Benson, M. D., Wells, Q. S., Celik, S., Lejonberg, C., Farrell, L. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13306-y · Cited by 99
Vascular surveillance by haptotactic blood platelets in inflammation and infection
Nicolai, L., Schiefelbein, K., Lipsky, S., Leunig, A., Hoffknecht, M., Pekayvaz, K., Raude, B., Marx, C., Ehrlich, A., Pircher, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19515-0 · Cited by 103
Controlling coagulation dysregulation in xenotransplantation
Cowan, P. J., Robson, S. C., & d’Apice, A. J. F. (2011) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283446c65 · Cited by 97
Hechler, B., Nonne, C., Eckly, A. E., Magnenat, S., Rinckel, J., Denis, C. V., Freund, M., Cazenave, J., Lanza, F., & Gachet, C. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03666.x · Cited by 95
Chemistry of Food Additives and Preservatives
Msagati, T. A. M. (2012) · Wiley eBooks · doi:10.1002/9781118274132 · Cited by 95
A Practical Guide to Wound Healing
Janis, J. E., Kwon, R. K., & Lalonde, D. H. (2010) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0b013e3181d9a0d1 · Cited by 94
Nie, C., Ma, L., Cheng, C., Deng, J., & Zhao, C. (2015) · Biomacromolecules · doi:10.1021/bm501882b · Cited by 90
Natural Products for Antithrombosis
Chen, C., Yang, F.-Q., Zhang, Q., Wang, F., Yuanjia, H., & Xia, Z. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/876426 · Cited by 111
“The extrinsic and intrinsic coagulation systems are initiated after vascular disruption via TF and collagen, respectively [8].”
BackgroundPlatelets and Metastasis: New Implications of an Old Interplay
Lucotti, S., & Muschel, R. J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01350 · Cited by 96
Recent Advances in the Development of Theranostic Nanoparticles for Cardiovascular Diseases
Wu, Y., Vazquez‐Prada, K. X., Liu, Y., Whittaker, A. K., Zhang, R., & Ta, H. T. (2021) · Nanotheranostics · doi:10.7150/ntno.62730 · Cited by 97
“Pathological arterial thrombosis is formed by complex interactions between environmental and genetic factors [72].”
BackgroundMolecular diversity of anticoagulants from haematophagous animals
Koh, C. Y., & Kini, R. M. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-04-0221 · Cited by 92
“The molecular diversity among the anticoagulants can be discussed under two categories: (1) functional divergence among closely related proteins, and (2) functional convergence of structurally unrelated proteins.”
BackgroundLaurent, P.-A., Séverin, S., Gratacap, M., & Payrastre, B. (2013) · Advances in Biological Regulation · doi:10.1016/j.jbior.2013.09.006 · Cited by 92
“Platelet activation and formation of an arterial thrombus is a highly regulated process involving a multistep adhesion mechanism (Furie and Furie, 2008).”
BackgroundLi, Y., Sun, K., Ye, G., Liang, Y., Pan, H., Wang, G., Zhao, Y., Pan, J., Zhang, J., & Fang, J. (2015) · Journal of Endodontics · doi:10.1016/j.joen.2014.10.020 · Cited by 102
Endale, M., Lee, W., Kamruzzaman, S., Kim, S., Park, J., Park, M., Park, T., Park, H., Cho, J., & Rhee, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01967.x · Cited by 90
“…activation triggered by pathophysiological factors can lead to the development and progression of cardiovascular disorders such as thrombosis (Furie and Furie, 2008), atherosclerosis (Huo et al., 2003), hypertension (Perros et al., 2008) and inflammation (Gawaz et al., 2005; Zarbock et al.,…”
BackgroundVenous and arterial thrombosis – pathogenesis and the rationale for anticoagulation
Esmon, C. T., & Turpie, A. G. G. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-10-0683 · Cited by 95
“The initiation phase is localised to cells that express TF (8, 12).”
BackgroundInfluentialBhowmick, R., Sarwar, M. S., Dewan, S. M. R., Das, A., Das, B., Uddin, M. M. N., Islam, M. S., & Islam, M. S. (2014) · Biological Research · doi:10.1186/0717-6287-47-56 · Cited by 107
“Discussion Thrombosis or blood clot formation is a critical event in which the damaged regions of the endothelial cell surface or blood vessel are blocked by the deposition of platelets, tissue factor and fibrin [15].”
BackgroundTrauma-Induced Coagulopathy: An Institution’s 35 Year Perspective on Practice and Research
González, E., Moore, E. E., Moore, H. B., Chapman, M. P., Silliman, C. C., & Banerjee, A. M. (2014) · Scandinavian Journal of Surgery · doi:10.1177/1457496914531927 · Cited by 89
“For instance, thrombin liberates fibrinopeptides from fibrinogen, allowing their association with other soluble fibrin molecules, and subsequently thrombin-activated factor XIII converts soluble into cross-linked fibrin (13).”
BackgroundInfluentialJiang, Y., Lei, C., Yasumoto, A., Kobayashi, H., Aisaka, Y., Ito, T., Guo, B., Nitta, N., Kutsuna, N., Ozeki, Y., et al. (2017) · Lab on a Chip · doi:10.1039/c7lc00396j · Cited by 96
Holy, E. W., Forestier, M., Richter, E. K., Akhmedov, A., Leiber, F., Camici, G. G., Mocharla, P., Lüscher, T. F., Beer, J. H., & Tanner, F. C. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.226118 · Cited by 88
Platelet in thrombo-inflammation: Unraveling new therapeutic targets
Sharma, S. H., Tyagi, T., & Antoniak, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039843 · Cited by 99
Thromboembolic disease in vasculitis
Tómasson, G., Monach, P. A., & Merkel, P. A. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32831de4e7 · Cited by 88
Nitric oxide based strategies for applications of biomedical devices
Yang, Y., Qi, P., Yang, Z., & Huang, N. (2015) · Biosurface and Biotribology · doi:10.1016/j.bsbt.2015.08.003 · Cited by 93
Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke
Kapil, N., Datta, Y. H., Alakbarova, N., Bershad, E. M., Selim, M. H., Liebeskind, D. S., Bachour, O., Rao, G. H. R., & Divani, A. A. (2016) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029616660762 · Cited by 94
“Thrombin converts fibrinogen to fibrin, and also it cleaves proteaseactivated receptor 1 on the platelet surface to activate platelets.(3) Activated platelets release a variety of chemical substrates—such as adenosine diphosphate (ADP), serotonin, and TXA2—that function as a positive feedback loop to activate more pla…”
BackgroundInfluentialThe gut microbiome and thromboembolism
Hasan, R. A., Koh, A. Y., & Zia, A. N. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.03.003 · Cited by 90
Kulkarni, P. P., Tiwari, A., Singh, N. K., Gautam, D., Sonkar, V. K., Agarwal, V., & Dash, D. (2018) · Haematologica · doi:10.3324/haematol.2018.205724 · Cited by 87
“A similar but more exaggerated response from platelets upon rupture of an atherosclerotic plaque leads to arterial thrombosis with potentially fatal consequences, such as myocardial infarction and ischemic stroke.(3) Platelet responses to agonist stimulation, including adhesion, shape change, integrin activation, aggr…”
BackgroundDecellularized scaffolds for tissue engineering: Current status and future perspective
Rajab, T. K., O’Malley, T. J., & Tchantchaleishvili, V. (2020) · Artificial Organs · doi:10.1111/aor.13701 · Cited by 93
Wang, S., Wang, R., Meng, N., Guo, H., Wu, S., Wang, X., Li, J., Wang, H., Jiang, K., Xie, C., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.030 · Cited by 88
Thrombin: A Pivotal Player in Hemostasis and Beyond
Larsen, J. B., & Hvas, A. (2021) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0041-1727116 · Cited by 93
Ellagic acid encapsulated chitosan nanoparticles as anti-hemorrhagic agent
Gopalakrishnan, L., Ramana, L. N., Sethuraman, S., & Krishnan, U. M. (2014) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2014.03.093 · Cited by 90
Emran, T. B., Rahman, M. A., Uddin, M. M. N., Rahman, M. M., Uddin, M. Z., Dash, R., & Layzu, C. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0643-2 · Cited by 96
“Because of the shortcomings of the available thrombolytic drugs, attempts are underway to develop improved recombinant variants of these drugs [4,5].”
BackgroundAdvanced drug delivery system against ischemic stroke
Zhang, S., Zhou, Y., Li, R., Chen, Z., & Fan, X. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.02.036 · Cited by 88
Red Blood Cell Microparticles: Clinical Relevance
Rubin, O., Canellini, G., Delobel, J., Lion, N., & Tissot, J. (2012) · Transfusion Medicine and Hemotherapy · doi:10.1159/000342228 · Cited by 95
McMichael, M. (2012) · Topics in companion animal medicine · doi:10.1053/j.tcam.2012.07.005 · Cited by 112
Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion
Zhu, Q. M., Yamakuchi, M., Ture, S. K., García-Hernández, M. D. L. L., Ko, K. A., Modjeski, K. L., LoMonaco, M. B., Johnson, A. D., O’Donnell, C. J., Takai, Y., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71245 · Cited by 84
“org Volume 124 Number 10 October 2014 Introduction Venous thromboembolism is a major cause of morbidity and mortality (1, 2).”
Pathophysiology of Bleeding and Clotting in the Cardiac Surgery Patient
Achneck, H. E., Sileshi, B., Parikh, A., Milano, C. A., Welsby, I. J., & Lawson, J. H. (2010) · Circulation · doi:10.1161/circulationaha.110.936773 · Cited by 84
Chen, B., Guo, L., Fan, C., Bolisetty, S., Joseph, R., Wright, M. M., Agarwal, A., & George, J. F. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081033 · Cited by 88
Early and Transient Release of Leukocyte Pentraxin 3 during Acute Myocardial Infarction
Maugeri, N., Rovere, P. Q., Slavich, M., Coppi, G., Doni, A., Bottazzi, B., Garlanda, C., Cianflone, D., Maseri, A., Mantovani, A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100261 · Cited by 91
Update on Postsurgical Scar Management
Commander, S. J., Chamata, E. S., Cox, J., Dickey, R. M., & Lee, E. B. (2016) · Seminars in Plastic Surgery · doi:10.1055/s-0036-1584824 · Cited by 86
Air pollutants: The key stages in the pathway towards the development of cardiovascular disorders
Shrey, K., Ahuja, S., Dogra, D., Shruti, K., & Vibha, R. (2010) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2010.09.002 · Cited by 87
Current state and future perspective of cardiovascular medicines derived from natural products
Zhao, C., Li, S., Zhang, J., Huang, Y., Zhang, L., Zhao, F., Du, X., Hou, J., Zhang, T., Shi, C.-J., et al. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107698 · Cited by 85
Qin, X., He, J., Wang, X., Wang, J., Yang, R., & Chen, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1256687 · Cited by 81
“Trauma induces pathophysiological changes that result in endothelial disruption; basement membrane exposure; and subsequent contact between flowing blood, collagen, and tissue factors, ultimately leading to thrombosis (80).”
BackgroundBorissoff, J. I., Joosen, I. A., Versteylen, M. O., Spronk, H. M. H., Cate, H. T., & Hofstra, L. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.01.023 · Cited by 85
Ultrasound-Propelled Janus Rod-Shaped Micromotors for Site-Specific Sonodynamic Thrombolysis
Cao, W., Liu, Y., Ran, P., He, J., Xie, S., Weng, J., & Li, X. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c19288 · Cited by 79
Extracellular Thiol Isomerases and Their Role in Thrombus Formation
Schulman, S., Bendapudi, P., Sharda, A., Chen, V., Bellido-Martin, L., Jasuja, R., Furie, B. C., Flaumenhaft, R., & Furie, B. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2015.6530 · Cited by 79
“Thrombus formation is a host defense mechanism to minimize the loss of blood following a breach in the high-pressure circulatory system (30).”
BackgroundSelf-citationDate, K. L., Ettelaie, C., & Maraveyas, A. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13871 · Cited by 78
“For example, in the setting of inflammatory conditions, such as sepsis and endotoxaemia, which can induce a hypercoagulable state, acute DIC only results when regulatory mechanisms are overwhelmed [100].”
BackgroundMicroRNA-223 inhibits tissue factor expression in vascular endothelial cells
Li, S., Chen, H., Ren, J., Geng, Q., Song, J., Lee, C., Cao, C., Zhang, J., & Xu, N. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.09.033 · Cited by 80
“Once atherosclerotic plaque ruptures, TF in ruptured plaque will be released to the blood flow [5,6].”
BackgroundSchmaier, A. A., Stalker, T. J., Runge, J. J., Lee, D., Nagaswami, C., Mericko, P. A., Chen, M., Cliché, S., Gariépy, C., Brass, L. F., et al. (2011) · Blood · doi:10.1182/blood-2011-02-338244 · Cited by 78
Epidemiology, risk and outcomes of venous thromboembolism in cancer
Russo, L., & Falanga, A. (2011) · Hämostaseologie · doi:10.5482/ha-1170 · Cited by 78
“In particular, TF supports tumour growth and metastasis by coagulation-independent mechanisms, involving VEGF up-regulation and PAR-2 activation (68).”
BackgroundNovotny, J., Chandraratne, S., Weinberger, T., Philippi, V., Stark, K., Ehrlich, A., Pircher, J., Konrad, I., Oberdieck, P., Titova, A., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190728 · Cited by 88
Tu, Q., Shen, X., Liu, Y., Zhang, Q., Zhao, X., Maitz, M. F., Liu, T., Qiu, H., Wang, J., Huang, N., et al. (2018) · Materials Chemistry Frontiers · doi:10.1039/c8qm00458g · Cited by 78
Insights from thrombi retrieved in stroke due to large vessel occlusion
Bacigaluppi, M., Semerano, A., Gullotta, G. S., & Strambo, D. (2019) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x19856131 · Cited by 77
Mechanical behavior of in vitro blood clots and the implications for acute ischemic stroke treatment
Johnson, S., Chueh, J.-Y., Gounis, M. J., McCarthy, R., McGarry, P., McHugh, P. E., & Gilvarry, M. (2019) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2019-015489 · Cited by 78
“9 After solidification of the blood, platelet-driven clot contraction tightens the fibrin network by gathering fibrin strands to adhered platelets.”
Approaches towards fighting the COVID‑19 pandemic (Review)
Tsai, S., Lu, C., BAU, D.-T., Chiu, Y., Yen, Y., Hsu, Y., Fu, C., Kuo, S., Lo, Y., Chiu, H., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4794 · Cited by 89
Fang, S. H., Ellman, D. G., & Andersen, D. C. (2021) · Cells · doi:10.3390/cells10030713 · Cited by 84
Statin use and the prevention of venous thromboembolism: a meta-analysis
Agarwal, V., Phung, O. J., Tongbram, V., Bhardwaj, A., & Coleman, C. I. (2010) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02439.x · Cited by 77
Proteomics of microparticles after deep venous thrombosis
Ramacciotti, E., Hawley, A. E., Wrobleski, S. K., Myers, D. D., Strahler, J. R., Andrews, P., Guire, K. E., Henke, P. K., & Wakefield, T. W. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.019 · Cited by 77
“Additionally, TF has been reported on MP by ELISA methods [30], but themajority of recent studies addressingMP Proteomics also have not detected TF.”
BackgroundVörös, E., Cho, M., Ramirez, M., Palange, A. L., Rosa, E. D., Key, J., Garami, Z. F., Lumsden, A. B., & Decuzzi, P. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201404354 · Cited by 77
Differential Dynamics of Platelet Contact and Spreading
Lee, D., Fong, K. P., King, M. R., Brass, L. F., & Hammer, D. A. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2011.10.056 · Cited by 77
Deppermann, C., Kraft, P., Volz, J., Schuhmann, M. K., Beck, S., Wolf, K., Stegner, D., Stoll, G., & Nieswandt, B. (2017) · Blood · doi:10.1182/blood-2016-12-750711 · Cited by 77
Bader, K. B., Bouchoux, G., & Holland, C. K. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22536-4_19 · Cited by 79
Advances in Enhancing Hemocompatibility of Hemodialysis Hollow-Fiber Membranes
Ji, H., Li, Y., Su, B., Zhao, W., Kizhakkedathu, J. N., & Zhao, C. (2023) · Advanced Fiber Materials · doi:10.1007/s42765-023-00277-5 · Cited by 81
Spath, B., Friedrich, M. G., Chun, F. K. ‐., Marx, G., Amirkhosravi, A., Francis, J., Bokemeyer, C., Eifrig, B., Haubold, K., Rink, M., et al. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0654 · Cited by 76
“The latter include, but may not be limited to, TF homo-dimerisation, lipid organisation, co-expression of TF pathway inhibitor, and reduction of the Cys186-Cys209 disulfide bond in the extracellular TF domain (39).”
BackgroundThe skin and hypercoagulable states
Thornsberry, L. A., LoSicco, K., & English, J. C. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.01.043 · Cited by 76
Principles of hemostasis in children: models and maturation
Guzzetta, N. A., & Miller, B. E. (2010) · Pediatric Anesthesia · doi:10.1111/j.1460-9592.2010.03410.x · Cited by 76
Heparin mimetics with anticoagulant activity
Al‐Nahain, A., Ignjatović, V., Monagle, P., Tsanaktsidis, J., & Ferro, V. (2018) · Medicinal Research Reviews · doi:10.1002/med.21489 · Cited by 78
Role of Factor XIa and Plasma Kallikrein in Arterial and Venous Thrombosis
Visser, M., Heitmeier, S., Cate, H. T., & Spronk, H. M. H. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710013 · Cited by 79
The molecular basis for the prothrombotic state in sickle cell disease
Shet, A. S., Lizarralde-Iragorri, M. A., & Naik, R. P. P. (2020) · Haematologica · doi:10.3324/haematol.2019.239350 · Cited by 85
Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?
Liang, H., Zhang, Q., Hu, Y., Liu, G., & Qi, R. (2022) · Journal of Stroke · doi:10.5853/jos.2021.02831 · Cited by 85
Yunoki, K., Naruko, T., Sugioka, K., Inaba, M., Iwasa, Y., Komatsu, R., Itoh, A., Haze, K., Inoue, T., Yoshiyama, M., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr486 · Cited by 74
Gold nanoparticles in cardiovascular imaging
Varna, M., Xuan, H. V., & Fort, E. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1470 · Cited by 78
Biotechnology, Bioengineering and Applications of Bacillus Nattokinase
Li, Y., Chen, L., Tang, X., & Li, J. (2022) · Biomolecules · doi:10.3390/biom12070980 · Cited by 78
Multifunctional agents for concurrent imaging and therapy in cardiovascular disease
McCarthy, J. R. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.004 · Cited by 75
Acellular Dermal Matrix: General Principles for the Plastic Surgeon
Fosnot, J., Kovach, S. J., & Serletti, J. M. (2011) · Aesthetic Surgery Journal · doi:10.1177/1090820x11417576 · Cited by 73
Gao, H., Liu, L., Zhao, Y., Hara, H., Chen, P., Xu, J., Tang, J., Wei, L., Li, Z., Cooper, D. K. C., et al. (2017) · Xenotransplantation · doi:10.1111/xen.12291 · Cited by 74
Current status of xenotransplantation research and the strategies for preventing xenograft rejection
Zhou, Q., Li, T., Wang, K., Zhang, Q., Geng, Z., Deng, S., Cheng, C., & Wang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.928173 · Cited by 87
“Simultaneously, subendothelial collagen triggers the accumulation and activation of platelets (123).”
BackgroundMaino, A., Rosendaal, F. R., Algra, A., Peyvandi, F., & Siegerink, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0133523 · Cited by 72
Chen, Z., Mondal, N. K., Ding, J., Gao, J., Griffith, B. P., & Wu, Z. J. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.01.030 · Cited by 76
Platelet Control of Fibrin Distribution and Microelasticity in Thrombus Formation Under Flow
Swieringa, F., Baaten, C. C. F. M. J., Verdoold, R., Mastenbroek, T. G., Rijnveld, N., van der Laan, K. O., Breel, E. J., Collins, P. W., Lance, M. D., Henskens, Y., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306537 · Cited by 79
“Exposure of the vasculature to FeCl 3 , resulting in endothelial denudation, leads to collagen-dependent platelet activation with an additional role of TF, particularly upon milder FeCl 3 injury.4–7 Thrombin and fibrin generations are elicited on procoagulant platelets exposing phosphatidylserine.8,9 Platelets, furthe…”
BackgroundInfluentialThe role of polyphenols in cardiovascular disease.
Michalska, M., Gluba-Brzózka, A., Mikhailidis, D. P., Nowak, P. J., Bielecka-Dabrowa, A. M., Rysz, J., & Banach, M. (2010) · PubMed · Cited by 86
Mosevoll, K. A., Johansen, S., Wendelbo, Ø., Nepstad, I., Bruserud, Ø., & Reikvam, H. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00147 · Cited by 78
Protein disulfide isomerase in thrombosis and vascular inflammation
Cho, J. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12413 · Cited by 70
Li, S., Ren, J., Xu, N., Zhang, J., Geng, Q., Cao, C., Lee, C., Song, J., Li, J., & Chen, H. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.06.017 · Cited by 74
The chemistry and biological activities of Peperomia pellucida (Piperaceae): A critical review
Alves, N. S. F., Setzer, W. N., & da Silva, J. K. R. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.12.021 · Cited by 76
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
Galli, M., Laborante, R., Ortega‐Paz, L., Franchi, F., Rollini, F., D’Amario, D., Capodanno, D., Tremoli, E., Gibson, C. M., Mehran, R., et al. (2023) · Thrombosis and Haemostasis · doi:10.1055/a-2043-0346 · Cited by 69
Diet and Thrombosis Risk: Nutrients for Prevention of Thrombotic Disease
Phang, M., Lazarus, S. A., Wood, L. G., & Garg, M. L. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0031-1273084 · Cited by 82
Ma, D., Mizurini, D. M., Assumpção, T. C. F., Li, Y., Qi, Y., Kotsyfakis, M., Ribeiro, J. M. C., Monteiro, R. Q., & Francischetti, I. M. B. (2013) · Blood · doi:10.1182/blood-2013-08-517474 · Cited by 71
“The coagulation cascade is regulated by several plasma inhibitors, including tissue factor pathway inhibitor (TFPI), activated protein C, antithrombin, heparin cofactor II, protease nexin I and II, C1 inhibitor, a-1-protease inhibitor, and a-2-antiplasmin.(1,2,12,13) Several other coagulation inhibitors have been char…”
BackgroundSeehaus, S., Shahzad, K., Kashif, M., Vinnikov, I. A., Schiller, M. R., Wang, H., Madhusudhan, T., Eckstein, V., Bierhaus, A., Bea, F., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.849539 · Cited by 69
Hu, J., Huang, W., Huang, S., Zhuge, Q., Jin, K., & Zhao, Y. (2016) · Nano Research · doi:10.1007/s12274-016-1152-4 · Cited by 69
Thrombosis in immune thrombocytopenia — current status and future perspectives
Swan, D., Newland, A. C., Rodeghiero, F., & Thachil, J. V. (2021) · British Journal of Haematology · doi:10.1111/bjh.17390 · Cited by 81
Platelets and SARS-CoV-2 During COVID-19: Immunity, Thrombosis, and Beyond
Sciaudone, A. R., Corkrey, H. A., Humphries, F., & Koupenova, M. (2023) · Circulation Research · doi:10.1161/circresaha.122.321930 · Cited by 71
Markelc, B., Bellard, E., Serša, G., Jesenko, T., Pélofy, S., Teissié, J., Frangež, R., Rols, M., Čemažar, M., & Golzio, M. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.032 · Cited by 77
Thrombosis in Cerebral Aneurysms and the Computational Modeling Thereof: A Review
Ngoepe, M., Frangi, A. F., Byrne, J. V., & Ventikos, Y. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00306 · Cited by 68
“For both processes, tissue factor must initiate the series of clotting reactions that result in the formation of a fibrin mesh, however the source of this tissue factor is thought to differ (Bugge et al., 1996; Carmeliet et al., 1996; Toomey et al., 1996; Hoffman, 2003, 2004; Hoffman et al., 2006; Mann, 2006; Furie an…”
BackgroundTransfusion strategies in postinjury coagulopathy
Stahel, P. F., Moore, E. E., Schreier, S. L., Flierl, M. A., & Kashuk, J. L. (2009) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32832678ed · Cited by 68
van Adrichem, R. A., Debeij, J., Nelissen, R. G. H. H., Schipper, I. B., Rosendaal, F. R., & Cannegieter, S. C. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12655 · Cited by 72
Platelet function and HIV: a case–control study
Satchell, C. S., Cotter, A. G., O’Connor, E., Peace, A. J., Tedesco, A. F., Clare, A., Lambert, J. S., Sheehan, G. J., Kenny, D. J., & Mallon, P. W. G. (2010) · AIDS · doi:10.1097/qad.0b013e328336098c · Cited by 75
“Several studies have demonstrated that arterial thrombus formation is a major factor in acute vascular events such as myocardial infarction (MI) in the general population [5,6].”
BackgroundAnalysis of tissue factor positive microparticles
Key, N. S. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.01.035 · Cited by 67
“These inconsistencies have been interpreted to be a result of the particular experimental trigger used to initiate thrombus formation, specifically whether the triggering stimulus leads to endothelial denudation and exposure of the high concentrations of sub-endothelial TF (11).”
BackgroundKashuk, J. L., Moore, E. E., Le, T. D., Lawrence, J., Pezold, M. L., Johnson, J. L., Cothren, C. C., Biffl, W. L., Barnett, C. C., & Sabel, A. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.03.046 · Cited by 67
“Furthermore, thrombin affects platelet function due to the combined effects with factor VIII and von-Willebrand factor [15].”
BackgroundPolysaccharide Nanosystems for Future Progress in Cardiovascular Pathologies
Silva, A., Letourneur, D., & Chauvierre, C. (2014) · Theranostics · doi:10.7150/thno.7688 · Cited by 70
“They also account for considerable morbidity and mortality worldwide, representing a substantial economic burden.[27, 28] Atherosclerosis is an important arterial wall disease characterized by focal lesions with asymmetric thickenings of the innermost layer of the artery that may lead to ischemia of the heart, brain,…”
BackgroundChowdary, P. (2018) · International Journal of Hematology · doi:10.1007/s12185-018-2548-6 · Cited by 69
CRISPR/Cas Technology in Pig-to-Human Xenotransplantation Research
Ryczek, N., Hryhorowicz, M., Zeyland, J., Lipiński, D., & Słomski, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063196 · Cited by 73
Metadata
- Authors
- Furie, B., & Furie, B. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- ORCID
- Furie, Bruce
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-08-28
- Volume
- 359
- Issue
- 9
- Pages
- 938-949
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1983760732
- Cited by
- 1,926
- References
- 122
- Citations by year
- 2026: 75 · 2025: 119 · 2024: 114 · 2023: 121 · 2022: 110 · 2021: 117 · 2020: 103 · 2019: 96 · 2018: 93 · 2017: 109 · 2016: 108 · 2015: 122 · 2014: 101 · 2013: 119 · 2012: 106
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL087203)
- Topics
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombus formation, hemostasis, platelet recruitment, coagulation, tissue factor, thrombin, fibrin, vascular injury, coagulation regulation
- MeSH terms
- Animals, Blood Coagulation, Blood Coagulation Disorders, Fibrinolytic Agents, Humans, Neoplasms, Thrombosis, Platelet Activation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.